MicroRNA Expression and Response to Sorafenib, Cytarabine, and Idarubicin in Patients with Acute Myeloid Leukemia

被引：0
|
作者：
Powers, M. P.
Rushton, J. R.
Yao, H.
Barkoh, B. A.
Jones, D.
Luthra, R.
机构：
[1] BCM, Houston, TX USA
[2] MDACC, Houston, TX USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1904
引用
收藏
页码：427A / 427A
页数：1
相关论文
共 50 条
  • [1] MicroRNA Expression and Response to Sorafenib, Cytarabine, and Idarubicin in Patients with Acute Myeloid Leukemia
    Powers, M. P.
    Rushton, J. R.
    Yao, H.
    Barkoh, B. A.
    Jones, D.
    Luthra, R.
    LABORATORY INVESTIGATION, 2010, 90 : 427A - 427A
  • [2] Final Report of Combination of Sorafenib, Idarubicin, and Cytarabine for Initial Therapy in Younger Patients with Acute Myeloid Leukemia
    Yi, Cecilia Y. Arana
    Cortes, Jorge
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Konopleva, Marina
    Estrov, Zeev
    O'Brien, Susan
    Borthakur, Gautam
    Levis, Mark J.
    Thomas, Deborah A.
    Pierce, Sherry A.
    Brandt, Mark
    Pratz, Keith W.
    Luthra, Rajyalakshmi
    Andreeff, Michael
    Kantarjian, Hagop M.
    Ravandi, Farhad
    BLOOD, 2012, 120 (21)
  • [3] Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia
    Ravandi, Farhad
    Cortes, Jorge E.
    Jones, Daniel
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Konopleva, Marina Y.
    O'Brien, Susan
    Estrov, Zeev
    Borthakur, Gautam
    Thomas, Deborah
    Pierce, Sherry R.
    Brandt, Mark
    Byrd, Anna
    Bekele, B. Nebiyou
    Pratz, Keith
    Luthra, Rajyalakshmi
    Levis, Mark
    Andreeff, Michael
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1856 - 1862
  • [4] Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia
    Al-Kali, Aref
    Cortes, Jorge
    Faderl, Stefan
    Jones, Dan
    Abril, Caroline
    Pierce, Sherry
    Brandt, Mark
    Kantarjian, Hagop
    Ravandi, Farhad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (04): : 361 - 366
  • [5] Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine
    Wiedower, Eric
    Jamy, Omer
    Martin, Michael G.
    ANTICANCER RESEARCH, 2015, 35 (11) : 6287 - 6290
  • [6] Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia
    F Ravandi
    C Arana Yi
    J E Cortes
    M Levis
    S Faderl
    G Garcia-Manero
    E Jabbour
    M Konopleva
    S O'Brien
    Z Estrov
    G Borthakur
    D Thomas
    S Pierce
    M Brandt
    K Pratz
    R Luthra
    M Andreeff
    H Kantarjian
    Leukemia, 2014, 28 : 1543 - 1545
  • [7] Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia
    Ravandi, F.
    Yi, C. Arana
    Cortes, J. E.
    Levis, M.
    Faderl, S.
    Garcia-Manero, G.
    Jabbour, E.
    Konopleva, M.
    O'Brien, S.
    Estrov, Z.
    Borthakur, G.
    Thomas, D.
    Pierce, S.
    Brandt, M.
    Pratz, K.
    Luthra, R.
    Andreeff, M.
    Kantarjian, H.
    LEUKEMIA, 2014, 28 (07) : 1543 - 1545
  • [8] Combination of Sorafenib, Idarubicin, and Cytarabine Has a High Response Rate in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Younger Than 65 Years
    Ravandi, Farhad
    Cortes, Jorge
    Faderl, Stefan
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Borthakur, Gautam
    Pierce, Sherry
    Brandt, Mark
    Lang, Marites
    Zhang, Weiguo
    Luthra, Rajyalakshmi
    Jones, Dan
    Levis, Mark J.
    Konopleva, Marina
    Andreeff, Michael
    Kantarjian, Hagop M.
    BLOOD, 2008, 112 (11) : 285 - 285
  • [9] Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia
    Shahswar, Rabia
    Beutel, Gernot
    Gabdoulline, Razif
    Schwarzer, Adrian
    Kloos, Arnold
    Koenecke, Christian
    Stadler, Michael
    Gohring, Gudrun
    Behrens, Yvonne Lisa
    Li, Zhixiong
    Dallmann, Louisa-Kristin
    Klement, Piroska
    Albert, Catherin
    Wichmann, Martin
    Alwie, Yasmine
    Benner, Axel
    Saadati, Maral
    Ganser, Arnold
    Thol, Felicitas
    Heuser, Michael
    HAEMATOLOGICA, 2024, 109 (01) : 72 - 83
  • [10] Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients with Newly Diagnosed FLT3-Mutant Acute Myeloid Leukemia (AML)
    Al-Kali, Aref
    Jones, Dan
    Cortes, Jorge
    Faderl, Stefan
    Ao, Xue
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Konopleva, Marina
    Brandt, Mark
    Andreeff, Michael
    Kantarjian, Hagop
    Ravandi, Farhad
    BLOOD, 2009, 114 (22) : 820 - 821
12345